Literature detail

Characterization of Marburg virus glycoprotein in viral entry.

Balaji Manicassamy1 Jizhen Wang Emily Rumschlag Stéphanie Tymen Valentina Volchkova Viktor Volchkov Lijun Rong
Affiliations 1 institutions
  1. Department of Microbiology and Immunology, College of Medicine Research Building, University of Illinois at Chicago, 8133 COMRB, 909 S. Wolcott Ave., Chicago, IL 60612, USA.
PMID 16989883 2007 Virology eng ppublish
PubMed DOI Browse context

Article

Publication summary

One major determinant of host tropism for filoviruses is viral glycoprotein (GP), which is involved in receptor binding and viral entry. Compared to Ebola GP (EGP), Marburg GP (MGP) is less well characterized in viral entry. In this study, using a human immunodeficiency virus-based pseudotyped virus as a surrogate system, we have characterized the role of MGP in viral entry. We have shown that like EGP, the mucin-like region of MGP (289-501) is not essential for virus entry. We have developed a viral entry interference assay for filoviruses, and using this assay, we have demonstrated that transfection of EGP or MGP in target cells can interfere with EGP/HIV and MGP/HIV pseudotyped virus entry in a dose-dependent manner. These results are consistent with the notion that Ebola and Marburg viruses use the same or a related host molecule(s) for viral entry. Substitutions of the non-conserved residues in MGP1 did not impair MGP-mediated viral entry. Unlike that of EGP1, individual substitutions of many conserved residues of MGP1 exerted severe defects in MGP expression, incorporation to HIV virions, and thus its ability to mediate viral entry. These results indicate that MGP is more sensitive to substitutions of the conserved residues, suggesting that MGP may fold differently from EGP.

Virus Internalization Amino Acid Sequence Amino Acid Substitution Cell Line HIV Humans Marburgvirus Molecular Sequence Data Protein Structure, Tertiary Receptors, Virus Sequence Homology, Amino Acid Viral Envelope Proteins Viral Interference Virus Assembly envelope glycoprotein, Ebola virus GP-protein, Marburg virus

Structured evidence records

Evidence records

2 total
1 records
Extraction confidence 0.90
Key finding

Substitutions of conserved residues in the Marburg virus glycoprotein impaired its folding, virion incorporation, and capacity for viral entry, highlighting molecular features underlying differences from Ebola virus GP.

Virus
Host
Not specified
Location
Not specified
Supporting text

Unlike that of EGP1, individual substitutions of many conserved residues of MGP1 exerted severe defects in MGP expression, incorporation to HIV virions, and thus its ability to mediate viral entry. These results indicate that MGP is more sensitive to substitutions of the conserved residues, suggesting that MGP may fold differently from EGP.

Genes or proteins
glycoprotein; MGP1
Mechanism types
receptor_binding; cell_entry; protein_folding
1 records
Extraction confidence 0.95
Key finding

Ebola and Marburg virus glycoproteins mediate receptor binding and use the same or related host molecule(s) for viral entry.

Virus
Location
Not specified
Supporting text

Compared to Ebola GP (EGP), Marburg GP (MGP) is less well characterized in viral entry. Using a human immunodeficiency virus-based pseudotyped virus, the study showed that transfection of EGP or MGP in target cells can interfere with EGP/HIV and MGP/HIV pseudotyped virus entry, suggesting that Ebola and Marburg viruses use the same or a related host molecule(s) for viral entry.

Method
pseudovirus assay; viral entry interference assay
Receptors
host molecule(s)